CeriBell (CBLL) Competitors $15.31 -0.18 (-1.16%) Closing price 04:00 PM EasternExtended Trading$15.13 -0.18 (-1.18%) As of 07:15 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock CBLL vs. LIVN, LMAT, ENOV, NVCR, CNMD, WRBY, CDRE, KMTS, LQDA, and TNDMShould you be buying CeriBell stock or one of its competitors? The main competitors of CeriBell include LivaNova (LIVN), LeMaitre Vascular (LMAT), Enovis (ENOV), NovoCure (NVCR), CONMED (CNMD), Warby Parker (WRBY), Cadre (CDRE), Kestra Medical Technologies (KMTS), Liquidia (LQDA), and Tandem Diabetes Care (TNDM). These companies are all part of the "medical equipment" industry. CeriBell vs. LivaNova LeMaitre Vascular Enovis NovoCure CONMED Warby Parker Cadre Kestra Medical Technologies Liquidia Tandem Diabetes Care CeriBell (NASDAQ:CBLL) and LivaNova (NASDAQ:LIVN) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, risk, dividends, community ranking, valuation, analyst recommendations, media sentiment, profitability and earnings. Is CBLL or LIVN more profitable? LivaNova has a net margin of 1.91% compared to CeriBell's net margin of 0.00%. LivaNova's return on equity of 13.81% beat CeriBell's return on equity.Company Net Margins Return on Equity Return on Assets CeriBellN/A N/A N/A LivaNova 1.91%13.81%7.07% Does the MarketBeat Community prefer CBLL or LIVN? LivaNova received 395 more outperform votes than CeriBell when rated by MarketBeat users. However, 100.00% of users gave CeriBell an outperform vote while only 69.71% of users gave LivaNova an outperform vote. CompanyUnderperformOutperformCeriBellOutperform Votes10100.00% Underperform VotesNo VotesLivaNovaOutperform Votes40569.71% Underperform Votes17630.29% Which has stronger earnings & valuation, CBLL or LIVN? LivaNova has higher revenue and earnings than CeriBell. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCeriBell$65.44M8.39N/AN/AN/ALivaNova$1.25B1.62$17.55M$1.1432.68 Does the media prefer CBLL or LIVN? In the previous week, CeriBell had 5 more articles in the media than LivaNova. MarketBeat recorded 14 mentions for CeriBell and 9 mentions for LivaNova. LivaNova's average media sentiment score of 1.68 beat CeriBell's score of 0.58 indicating that LivaNova is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CeriBell 7 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive LivaNova 8 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Do analysts rate CBLL or LIVN? CeriBell presently has a consensus price target of $32.50, indicating a potential upside of 112.28%. LivaNova has a consensus price target of $61.17, indicating a potential upside of 64.16%. Given CeriBell's stronger consensus rating and higher possible upside, analysts clearly believe CeriBell is more favorable than LivaNova.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CeriBell 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 3.00LivaNova 0 Sell rating(s) 2 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 2.88 Do institutionals and insiders believe in CBLL or LIVN? 97.6% of LivaNova shares are held by institutional investors. 0.3% of LivaNova shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. SummaryLivaNova beats CeriBell on 9 of the 15 factors compared between the two stocks. Get CeriBell News Delivered to You Automatically Sign up to receive the latest news and ratings for CBLL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CBLL vs. The Competition Export to ExcelMetricCeriBellElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$549.14M$3.19B$5.44B$7.80BDividend YieldN/A1.82%5.43%4.30%P/E RatioN/A15.2422.1418.40Price / Sales8.3947.58389.70101.30Price / CashN/A44.0938.2034.62Price / BookN/A3.616.664.18Net IncomeN/A$94.03M$3.21B$247.71M7 Day Performance3.10%12.19%5.83%6.45%1 Month Performance-24.06%2.31%-4.32%-3.14%1 Year PerformanceN/A-13.97%17.83%5.40% CeriBell Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CBLLCeriBell1.9132 of 5 stars$15.31-1.2%$32.50+112.3%N/A$549.14M$65.44M0.00N/AInsider TradeNews CoverageLIVNLivaNova3.6613 of 5 stars$35.46+4.4%$61.17+72.5%-33.4%$1.93B$1.25B84.432,900Upcoming EarningsPositive NewsLMATLeMaitre Vascular2.3125 of 5 stars$83.78+1.2%$95.25+13.7%+43.3%$1.89B$219.86M45.78490Upcoming EarningsPositive NewsENOVEnovis2.6703 of 5 stars$32.28+0.8%$58.50+81.2%-37.5%$1.84B$2.11B-14.746,800Upcoming EarningsNews CoverageGap UpNVCRNovoCure3.2436 of 5 stars$16.55+0.3%$34.50+108.5%+50.3%$1.82B$605.22M-11.821,320Earnings ReportAnalyst ForecastNews CoverageGap UpCNMDCONMED4.779 of 5 stars$50.91-1.6%$77.20+51.6%-27.0%$1.57B$1.31B12.014,100Upcoming EarningsWRBYWarby Parker3.5771 of 5 stars$14.92+0.8%$22.71+52.2%+20.9%$1.55B$771.32M-55.263,030Analyst ForecastNews CoverageGap UpCDRECadre3.2382 of 5 stars$31.24+1.5%$37.00+18.4%-10.2%$1.27B$567.56M37.642,240Dividend AnnouncementNews CoveragePositive NewsKMTSKestra Medical TechnologiesN/A$23.83-1.9%$27.67+16.1%N/A$1.18B$45.82M0.00300LQDALiquidia2.687 of 5 stars$13.83+2.7%$26.63+92.5%+11.8%$1.18B$14.00M-8.4850News CoverageTNDMTandem Diabetes Care4.274 of 5 stars$17.03-0.2%$43.88+157.7%-49.7%$1.13B$940.20M-8.822,600Upcoming EarningsNews CoveragePositive News Related Companies and Tools Related Companies LivaNova Alternatives LeMaitre Vascular Alternatives Enovis Alternatives NovoCure Alternatives CONMED Alternatives Warby Parker Alternatives Cadre Alternatives Kestra Medical Technologies Alternatives Liquidia Alternatives Tandem Diabetes Care Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CBLL) was last updated on 4/25/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredTrump purposefully forcing markets to crash…Whether you agree with the plan or not doesn’t matter. It’s happening. The only question is – are you re...Porter & Company | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored🥾⛏️👷♂️ What I Learned From Numerous Mine Visits...Twenty years ago, I made a decision that changed my life. Instead of sitting behind a desk analyzing mining...Golden Portfolio | SponsoredTrump’s tariffs just split the AI market in twoTrump’s tariff just split the AI market – among others – in two. One group of AI companies—the ones relying...Traders Agency | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CeriBell Please log in to your account or sign up in order to add this asset to your watchlist. Share CeriBell With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CBLL Stock Free CBLL Stock Alerts